ClinicalTrials.Veeva

Menu

Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis

A

Ankara City Hospital

Status

Enrolling

Conditions

Psoriatic Arthritis

Study type

Observational

Funder types

Other

Identifiers

NCT06437392
10026356

Details and patient eligibility

About

The purpose of the study is identify the prevalence of sarcopenia and its associated factors in patients with psoriatic arthritis. Furthermore, we aimed to investigate the predictive contribution of USG in diagnosing sarcopenia by assessing the thickness of the rectus femoris, vastus intermedius, and quadriceps muscles in patients with psoriatic arthritis.

Full description

After being informed about study and potential risk, all patient and giving written informed consent will undergo screnneing determite eligibility for study entire. Participants who agree to take part in the study and sign the informed consent form will be divided into two groups: patients and healthy volunteers. The patients will undergo a rheumatological examination, and sarcopenia screening will be conducted for both groups. Additionally, the quadriceps muscle thickness of both groups will be measured.

Enrollment

102 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosed with psoriatic arthritis according to CASPAR criteria at least 1 year ago
  • Between 18 and 65 years old
  • Normal cognitive functions
  • Agrees to participate in the study
  • No changes in medical treatment for psoriatic arthritis in the last 3 months

Exclusion criteria

  • Those with neurological diseases
  • Those with hip dysplasia
  • Those with upper and lower extremity deformities
  • Those with upper and lower extremity joint arthroplasty
  • Those with arthritis and deformities in the hands
  • Those with lumbar stabilization
  • Those with cognitive impairment preventing participation in the study
  • Those with body weight beyond the device's measurement capacity
  • Those who do not agree to participate in the study

Trial design

102 participants in 2 patient groups

Psoriatic arthritis
Description:
Psoriatic arthritis patient
Healthy volunteer
Description:
Healthy Volunteer

Trial contacts and locations

1

Loading...

Central trial contact

Gonca Canan Dogan Tosun, Medical Doctor; Tuba Güler, Assoc Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems